We can’t show the full text here under this license. Use the link below to read it at the source.
A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry
Psychedelic-Assisted Therapies in Modern Psychiatry: Hopeful but Not a Cure-All
AI simplified
Abstract
Psychedelic-assisted therapies show promising therapeutic effects in treating conditions like treatment-resistant depression and PTSD.
- Psychedelics such as psilocybin and MDMA are being studied in controlled clinical trials for their potential benefits.
- These compounds may enhance neural plasticity and improve cognitive and emotional flexibility.
- Emerging evidence suggests that psychedelic therapies could lead to lasting clinical improvements.
- Challenges include regulatory uncertainty and ethical concerns regarding patient vulnerability.
- Equitable access to these therapies remains a significant issue in their integration into mental health care.
AI simplified